Cargando…
Drugs in development for toxoplasmosis: advances, challenges, and current status
Toxoplasma gondii causes fatal and debilitating brain and eye diseases. Medicines that are currently used to treat toxoplasmosis commonly have toxic side effects and require prolonged courses that range from weeks to more than a year. The need for long treatment durations and the risk of relapsing d...
Autores principales: | Alday, P Holland, Doggett, Joseph Stone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279849/ https://www.ncbi.nlm.nih.gov/pubmed/28182168 http://dx.doi.org/10.2147/DDDT.S60973 |
Ejemplares similares
-
Advances and Challenges in Diagnostics of Toxoplasmosis in HIV-Infected Patients
por: Wesołowski, Roland, et al.
Publicado: (2023) -
Advances and Challenges in Understanding Cerebral Toxoplasmosis
por: Schlüter, Dirk, et al.
Publicado: (2019) -
Toxoplasmosis: Current and Emerging Parasite Druggable Targets
por: Hajj, Rana El, et al.
Publicado: (2021) -
Management of severe sepsis: advances, challenges, and current status
por: Martin-Loeches, Ignacio, et al.
Publicado: (2015) -
Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches
por: Kalogeropoulos, Dimitrios, et al.
Publicado: (2021)